Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116169983 | 11616998 | 3 | F | 2009 | 20160721 | 20151009 | 20160803 | PER | US-BAYER-2015-435114 | BAYER | 0.00 | A | M | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116169983 | 11616998 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, UNK | 21085 | 400 | MG | FILM-COATED TABLET | ||||||||
| 116169983 | 11616998 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 21085 | FILM-COATED TABLET | |||||||||||
| 116169983 | 11616998 | 3 | SS | OFLOXACIN. | OFLOXACIN | 1 | 0.3 %, UNK | 0 | .3 | PCT | |||||||||
| 116169983 | 11616998 | 4 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD | ||||||||
| 116169983 | 11616998 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 20 /12.5 1 PER DAY | 0 | |||||||||||
| 116169983 | 11616998 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, QD | 0 | 50 | MG | QD | ||||||||
| 116169983 | 11616998 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 116169983 | 11616998 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 300MG 12 PER DAY | 0 | |||||||||||
| 116169983 | 11616998 | 9 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | 25 MG, QD | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116169983 | 11616998 | 1 | Sinusitis |
| 116169983 | 11616998 | 2 | Nasopharyngitis |
| 116169983 | 11616998 | 3 | Ear infection |
| 116169983 | 11616998 | 5 | Hypertension |
| 116169983 | 11616998 | 6 | Hypertension |
| 116169983 | 11616998 | 7 | Blood cholesterol |
| 116169983 | 11616998 | 8 | Neuropathy peripheral |
| 116169983 | 11616998 | 9 | Sleep disorder therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116169983 | 11616998 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116169983 | 11616998 | Anhedonia | |
| 116169983 | 11616998 | Anxiety | |
| 116169983 | 11616998 | Cardiovascular disorder | |
| 116169983 | 11616998 | Emotional distress | |
| 116169983 | 11616998 | Injury | |
| 116169983 | 11616998 | Mental disorder | |
| 116169983 | 11616998 | Musculoskeletal injury | |
| 116169983 | 11616998 | Musculoskeletal pain | |
| 116169983 | 11616998 | Nervous system disorder | |
| 116169983 | 11616998 | Neuropathy peripheral | |
| 116169983 | 11616998 | Pain | |
| 116169983 | 11616998 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116169983 | 11616998 | 1 | 20090927 | 0 | ||
| 116169983 | 11616998 | 3 | 20090922 | 0 |